Posts Tagged: Cell & Tissue Engineering
New Medicine by Design-funded research out of the lab of Michael Sefton continues to advance one of his lab’s goals: developing a cell-based treatment for type 1 diabetes that can be implanted under the skin and would eliminate the need for insulin injections.
Canadian scientists made one of the most important discoveries in the history of medicine 100 years ago when Dr. Frederick Banting and his assistant, Charles Best, successfully isolated the hormone insulin in Banting's lab at the University of Toronto.
In the 4th volume of Nature’s Communications Biology, researchers at TBEP published an important study that can reshape the way we engineer new blood vessels for patients who need them.
A new technology developed by researchers at the University of Toronto provides the first step in mimicking the environment of lung airways, enables scientists to perform particle exposure experiments to examine the pathological effect of air pollutants on respiratory health.
The science of rapid wound healing has new insights due to discoveries in fruit flies from the Fernandez-Gonzalez lab at University of Toronto. Collaboration, community and perseverance has resulted in an article published in the journal Cell Reports as “p38-mediated cell growth and survival drive rapid embryonic wound repair”.
Scientists out of two labs at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, and this method has the potential to rapidly advance the development of treatments for diseases like muscular dystrophy (MD) and other degenerative muscle conditions.
Professor Craig Simmons was inducted as a Biomedical Engineering Society (BMES) fellow among 19 other internationally recognized scientists and engineers. As a BMES fellow, Dr. Simmons was recognized internationally for his innovative and wide-ranging contributions to both fundamental science and practical applications in the field of mechanobiology.
Drs. Cristina Nostro and Sara Nunes Vasconcelos, with their postdoctoral fellow Dr. Yasaman Aghazadeh, have engineered a new method to improve the survival and potency of such cell transplants.
Michael Sefton, a U of T tissue engineer and executive director of Medicine by Design, is investigating whether dendritic skin cells can aid in the successful transplantation of insulin-producing islet cells in diabetes patients.
Showing 51 - 60 of 107 results